azathioprine has been researched along with Child Development Deviations in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azathioprine (AZA) is recognized among immunosuppressive medications as relatively safe during pregnancy for women with systemic lupus erythematosus (SLE) requiring aggressive treatment." | 3.79 | In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus. ( Ganser, MA; Gordon, C; Hyzy, MA; Marder, W; McCune, WJ; Romero, V; Somers, EC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marder, W | 1 |
| Ganser, MA | 1 |
| Romero, V | 1 |
| Hyzy, MA | 1 |
| Gordon, C | 1 |
| McCune, WJ | 1 |
| Somers, EC | 1 |
| Russo, RA | 1 |
| Katsicas, MM | 1 |
2 other studies available for azathioprine and Child Development Deviations
| Article | Year |
|---|---|
In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cohort Studies; Developmental Disabilities | 2013 |
Chronic infantile neurological cutaneous and articular syndrome: two new cases with rare manifestations.
Topics: Abnormalities, Multiple; Antirheumatic Agents; Arthritis; Azathioprine; Child, Preschool; Chronic Di | 2001 |